NCATS and National Institute of Diabetes and Digestive and Kidney Diseases researchers found that a drug used to treat allergy symptoms also limited hepatitis C virus activity in mice.
NCATS support to Yale team leads to expedited clinical trial to test experimental drug as Alzheimer's treatment.
Researchers tested the cells of more than 1,000 individuals with different genetic backgrounds for sensitivity to 179 therapeutic and industrial chemical compounds.
A financial analysis in Science Translational Medicine finds that two NCATS rare diseases programs have led to reduced cost of developing new drugs and reduced financial risks.
CTSA hubs are forming a national network to overcome barriers to participant recruitment for clinical trials.
MORE CENTER NEWS
Apply for Collaborative Innovation Awards to stimulate team-based research.
NIH research team works with industry to develop treatments for lysosomal storage disorders.
IN THE SPOTLIGHT
On April 2, 2015, NCATS released two funding opportunities through the Clinical and Translational Science Awards (CTSA) program. These awards will support innovative investigations among three or more CTSA hubs to improve research methods at any step of the translational process.